comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 02:27:52 - browse：62

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： A new nitrogen execution bill also undermines medical licensing

explore

hotspot

WSS

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Experimental asthma app from Apple and Anthem shows promise

He's a Nobel laureate. Critics say he was misleading on Covid

Antivenom research: Lessons from HIV applied in search for universal antidote

What is STAT's opinion section for?

Why palliative psychiatry is worth discussing

explore

comprehensive

entertainment

The high cost of giving birth even with insurance

Alabama frozen embryo ruling has major implications for IVF clinics

Dobbs anniversary: the lost opportunity of abortion as health care

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Bright Health sells Medicare Advantage business to Molina

Alabama IVF ruling threatens families facing fatal genetic disease

New air purifier tech could be key to improving indoor air quality

Ventyx halts psoriasis drug development after lackluster trial results

Medical records are filled with copy

A letter from the executive editor: STAT UnitedHealth investigation

knowledge

Study suggests Covid rebound is far more common with Paxlovid than without

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Ventyx halts psoriasis drug development after lackluster trial results

First transplant of an entire human eye performed

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

entertainment

explore

hotspot

focus